The Valley Desk

NCT00084513 · Interventional trial

Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer

Overall registry status Completed

Phase 1

Conditions Unspecified Adult Solid Tumor, Protocol Specific

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov